The price of paliperidone palmitate injections can vary based on several factors, including dosage, quantity, insurance coverage, and pharmacy. For example, a 3-month supply of paliperidone palmitate 175 mg intramuscular injection might range from $2,000 to $3,000 [1]. Similarly, a 1-month supply of paliperidone palmitate 75 mg intramuscular injection could cost between $600 and $800 [1].
How much do paliperidone palmitate injections typically cost without insurance?
Without insurance, the out-of-pocket cost for paliperidone palmitate injections can be substantial. For instance, a single vial of paliperidone palmitate 175 mg intramuscular injection might cost around $2,000 [1]. The 75 mg intramuscular injection could be approximately $700 per vial [1].
Are there patient assistance programs for paliperidone palmitate?
Yes, pharmaceutical manufacturers often provide patient assistance programs for their medications. For paliperidone palmitate, programs may offer eligible uninsured or underinsured patients the medication at a reduced cost or for free. Information on these programs can typically be found on the drug's official website or through healthcare provider resources [2].
When does the patent for paliperidone palmitate expire?
The patent landscape for paliperidone palmitate is complex and involves multiple patents covering the drug itself, its formulations, and methods of use. Some key patents related to paliperidone palmitate formulations and their use have expiration dates that have passed or are approaching. For instance, certain patents have expiration dates in the late 2020s [3]. DrugPatentWatch.com provides detailed information on patent status and expiration timelines for various drugs, including paliperidone palmitate [3].
What are the different dosages and strengths of paliperidone palmitate injections?
Paliperidone palmitate injections are available in various strengths to accommodate different patient needs and treatment regimens. Common strengths include 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, and 175 mg, administered via intramuscular injection [1]. These are typically available as long-acting injectable formulations.
What is paliperidone palmitate used to treat?
Paliperidone palmitate is an atypical antipsychotic medication used for the treatment of schizophrenia and schizoaffective disorder in adults [4]. It is administered as a long-acting injection, reducing the need for daily oral medication.
What are the potential side effects of paliperidone palmitate injections?
Common side effects associated with paliperidone palmitate injections can include injection site reactions (pain, redness, swelling), headache, insomnia, and weight gain. More serious side effects can occur, such as extrapyramidal symptoms (movement disorders), high prolactin levels, and tardive dyskinesia. Patients should discuss all potential risks and benefits with their healthcare provider [4].
How does paliperidone palmitate compare to other antipsychotic treatments?
Paliperidone palmitate offers a long-acting injectable option for managing schizophrenia and schizoaffective disorder, which can improve adherence compared to daily oral medications. It belongs to the class of atypical antipsychotics, similar to other medications like risperidone (which paliperidone is a metabolite of), olanzapine, and aripiprazole, each with their own efficacy profiles and side effect considerations [4]. The choice of treatment often depends on individual patient response, tolerability, and clinical history.
Sources:
[1] GoodRx
[2] Janssen Medical Information
[3] DrugPatentWatch.com
[4] National Institutes of Health